12/21/2009

The FDA approved the use of Spiriva Handihaler to reduce symptoms of chronic obstructive pulmonary disease. The inhaled drug is already marketed by Pfizer and Boehringer Ingelheim as once-daily maintenance treatment for COPD.

Related Summaries